{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:36:29Z","timestamp":1780328189940,"version":"3.54.1"},"reference-count":37,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100007614","name":"Deanship of Scientific Research at Jouf University","doi-asserted-by":"publisher","award":["DSR-2021-01-0352"],"award-info":[{"award-number":["DSR-2021-01-0352"]}],"id":[{"id":"10.13039\/501100007614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>We report on a case-control study with 126 participants, divided into 26 patients\nwith Ph-ve CML (57.7% male, 42.3% female) and 100 healthy volunteers (51% male, 49% female)\nwith no medical history of cancer as a control population. All Ph-ve CML patients were diagnosed\naccording to standard hematologic and cytogenetic criteria based on CBC, confirmed by Reverse\nTranscriptase Polymerase Chain Reaction (RT-PCR) to determine the presence or absence of the BCRABL\ngene, followed by bone marrow (BM) examination.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Our research aimed to clarify the role of genetic polymorphisms in GST (T1\nand M1) in the development of Ph-ve CML.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Of the 26 studied cases, 50% had the GSTT1 null genotype against 21% of the control group,\na statistically significant difference (CI= 1.519 - 9.317; p-value= 0.004). The GSTM1 null genotype\nwas detected in 23.1% of cases and 35% of controls, a difference not statistically significant (OR=\n0.557; CI= 0.205-1.515; p-value= 0.252). The distribution of GSTT1 and GSTM1 polymorphisms was\nalso examined according to gender, age and ethnic grouping; these findings revealed no statistically\nsignificant differences.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our study reveals a strong correlation between GSTT1 polymorphism and Ph-ve CML,\nwhereas the data for GSTM1 polymorphisms indicates no role in the initial development of the disease.\nMore studies are required to further clarify these and other genes' roles in disease development.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1568009623666221027103845","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T07:22:33Z","timestamp":1666941753000},"page":"319-324","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of GSTT1 and GSTM1 Polymorphisms in the Susceptibility to\nPhiladelphia Negative Chronic Myeloid Leukaemia"],"prefix":"10.2174","volume":"23","author":[{"given":"Abozer Y.","family":"Elderdery","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia"},{"name":"Health Sciences Research Unit, Jouf University, Sakaka, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeil M.E.","family":"Idris","sequence":"additional","affiliation":[{"name":"College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Entesar M.","family":"Tebien","sequence":"additional","affiliation":[{"name":"College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada Abdalfatah","family":"Diab","sequence":"additional","affiliation":[{"name":"University of Khartoum\/ Medical Laboratory Science Programme, Alhyatt\nUniversity College, Khortoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddiqa M.A.","family":"Hamza","sequence":"additional","affiliation":[{"name":"Department of Pathology, College of Medicine, Umm Alqura University,\nAlgunfuda, Saudi Arabia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandar A.","family":"Suliman","sequence":"additional","affiliation":[{"name":"College of Applied Medical Sciences, Taibah University, Medina, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz H.","family":"Alhamidi","sequence":"additional","affiliation":[{"name":"Clinical\nLaboratory Sciences Department, College of Applied Medical Science, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal Eltayeb","family":"Omer","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Pathology, Assafa College, Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Mills","sequence":"additional","affiliation":[{"name":"School of Pharmacy and\nBiomedical Sciences, University of Portsmouth, Portsmouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF01715120","volume":"65","author":"Montefusco E.","year":"1992","unstructured":"Montefusco E.; Alimena G.; Coco F.L.; De Cuia M.R.; Wang Y.Z.; Spiriti M.A.A.; Mancini F.; Cedrone M.; Mancini M.; Mandelli F.; pH-negative and BCR-negative atypical chronic myelogenous leukemia: Biological features and clinical outcome. Ann Hematol 1992,65(1),17-21","journal-title":"Ann Hematol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12032-014-0889-4","volume":"31","author":"Al-Achkar W.","year":"2014","unstructured":"Al-Achkar W.; Azeiz G.; Moassass F.; Wafa A.; Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population. Med Oncol 2014,31(5),889","journal-title":"Med Oncol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/cncr.10832","volume":"95","author":"Onida F.","year":"2002","unstructured":"Onida F.; Ball G.; Kantarjian H.M.; Smith T.L.; Glassman A.; Albitar M.; Scappini B.; Rios M.B.; Keating M.J.; Beran M.; Characteristics and outcome of patients with Philadelphia chromosome negative, BCR\/ABL negative chronic myelogenous leukemia. Cancer 2002,95(8),1673-1684","journal-title":"Cancer"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-415813-9.00003-9","volume":"112","author":"Croom E.","year":"2012","unstructured":"Croom E.; Metabolism of xenobiotics of human environments. Prog Mol Biol Transl Sci 2012,112,31-88","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"10316","DOI":"10.1021\/acs.est.6b01899","volume":"50","author":"Polesel F.","year":"2016","unstructured":"Polesel F.; Andersen H.R.; Trapp S.; Pl&#xF3;sz B.G.; Removal of antibiotics in biological wastewater treatment systems\u2014A critical assessment using the activated sludge modeling framework for xenobiotics (ASM-X). Environ Sci Technol 2016,50(19),10316-10334","journal-title":"Environ Sci Technol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1021\/acs.chemrestox.0c00535","volume":"34","author":"Kankanamage R.N.T.","year":"2021","unstructured":"Kankanamage R.N.T.; Sefcikova J.; Advancements of xenobiotic toxicity screening for the advancement of human health. Chem Res Toxicol 2021,34(7),1699-1700","journal-title":"Chem Res Toxicol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4236\/jct.2014.51001","volume":"5","author":"Elhoseiny S.","year":"2014","unstructured":"Elhoseiny S.; El-Wakil M.; Fawzy M.; Rahman A.A.; GSTP1 (Ile105Val) gene polymorphism: Risk and treatment response in chronic myeloid leukemia. J Cancer Ther 2014,5(1),1-10","journal-title":"J Cancer Ther"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2174\/1570163817666200518081356","volume":"20","author":"Idris H.M.E.","year":"2020","unstructured":"Idris H.M.E.; Khalil H.B.; Mills J.; Elderdery A.Y.; CYP1A1 and CYP2D6 polymorphisms and susceptibility to chronic myelocytic leukaemia. Curr Cancer Drug Targets 2020,20(9),675-680","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=9","first-page":"1325","volume":"13","year":"2019","unstructured":"Detection of Genetic polymorphisms of Methylene tetrahydrofolate reductase among Sudanese patients with chronic myeloid leukemia. PJMHS 2019,13(4),1325-1329","journal-title":"PJMHS"},{"key":"ref=10","first-page":"1330","volume":"13","year":"2019","unstructured":"The role of genetic polymorphisms of the MTHFR (C677T and A1298C) gene in the incidence of Acute Myeloid Leukaemia. PJMHS 2019,13(4),1330-1334","journal-title":"PJMHS"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e00717","DOI":"10.1002\/mgg3.717","volume":"7","author":"Rostami G.","year":"2019","unstructured":"Rostami G.; Assad D.; Ghadyani F.; Hamid M.; Karami A.; Jalaeikhoo H.; Kalahroodi R.A.; Influence of glutathione S;transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response. Mol Genet Genomic Med 2019,7(7),e00717","journal-title":"Mol Genet Genomic Med"},{"key":"ref=12","first-page":"2961","volume":"28","author":"Enr&#xED;quez-Mej&#xED;a M.G.","year":"2017","unstructured":"Enr&#xED;quez-Mej&#xED;a M.G.; Flores-Merino M.V.; Camacho A.L.; Castillo-Cadena J.; Frequency of single and combined genotypes of GSTM1, GSTT1 and GSTP1 in Mexican individuals: A pilot study. Biomed Res J 2017,28(7),2961-2965","journal-title":"Biomed Res J"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"19375","DOI":"10.1007\/s11356-020-08435-7","volume":"27","author":"Drozdz-Afelt J.M.","year":"2020","unstructured":"Drozdz-Afelt J.M.; Koim-Puchowska B.; Klosowski G.; Kaminski P.; Polymorphism of glutathione S-transferase in the population of polish patients with carcinoma of the prostate. Environ Sci Pollut Res Int 2020,27(16),19375-19382","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"e89302","DOI":"10.1371\/journal.pone.0089302","volume":"9","author":"Yang F.","year":"2014","unstructured":"Yang F.; Xiong J.; Jia X.E.; Gu Z.H.; Shi J.Y.; Zhao Y.; Li J.M.; Chen S.J.; Zhao W.L.; GSTT1 deletion is related to polycyclic aromatic hydrocarbons-induced DNA damage and lymphoma progression. PLoS One 2014,9(2),e89302","journal-title":"PLoS One"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00432-021-03769-2","volume":"148","author":"Jurkovic Mlakar S.","year":"2021","unstructured":"Jurkovic Mlakar S.; Uppugunduri S.C.R.; Nava T.; Mlakar V.; Golay H.; Robin S.; GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation. J Cancer Res Clin Oncol 2021,148(1),71-86","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11523-020-00696-z","volume":"15","author":"Lee N.","year":"2020","unstructured":"Lee N.; Park S.M.; Yee J.; Yoon H.Y.; Han J.M.; Gwak H.S.; Association between glutathione-S-transferase gene polymorphisms and responses to tyrosine kinase inhibitor treatment in patients with chronic myeloid leukemia: A meta-analysis. Target Oncol 2020,15(1),47-54","journal-title":"Target Oncol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s40064-015-0966-y","volume":"4","author":"Kassogue Y.","year":"2015","unstructured":"Kassogue Y.; Dehbi H.; Quachouh M.; Quessar A.; Benchekroun S.; Nadifi S.; Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia. Springerplus 2015,4(1),210","journal-title":"Springerplus"},{"key":"ref=18","first-page":"728","volume":"23","author":"Wang Y.Y.","year":"2015","unstructured":"Wang Y.Y.; Wang W.; Yang J.; Li G.L.; Zhuang L.K.; Lu L.L.; Relationship of GSTT1 and GSTM1 gene polymorphisms and PAH-DNA adducts with pathogenesis of multiple myeloma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2015,23(3),728-732","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/hon.1018","volume":"30","author":"&#xD6;zten N.","year":"2012","unstructured":"&#xD6;zten N.; ; Sunguro&#x11F;lu, A.; Bosland, M.C. Variations in glutathione-S-transferase genes influence risk of chronic myeloid leukemia. Hematol Oncol 2012,30(3),150-155","journal-title":"Hematol Oncol"},{"key":"ref=20","first-page":"12","volume":"138","author":"Taspinar M.","year":"2008","unstructured":"Taspinar M.; Aydos S.E.; Comez O.; Elhan A.H.; Karabulut H.G.; Sunguroglu A.; CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukemia. Swiss Med Wkly 2008,138(1-2),12-17","journal-title":"Swiss Med Wkly"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.18632\/aging.100418","volume":"3","author":"Ito M.","year":"2011","unstructured":"Ito M.; Imai M.; Muraki M.; Miyado K.; Qin J.; Kyuwa S.; Yoshikawa Y.; Hosoi Y.; Saito H.; Takahashi Y.; GSTT1 is upregulated by oxidative stress through p38-MK2 signaling pathway in human granulosa cells: Possible association with mitochondrial activity. Aging 2011,3(12),1213-1223","journal-title":"Aging"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3389\/fpls.2018.00751","volume":"9","author":"Kumar S.","year":"2018","unstructured":"Kumar S.; Trivedi P.K.; Glutathione S-transferases: Role in combating abiotic stresses including arsenic detoxification in plants. Front Plant Sci 2018,9(2),751-756","journal-title":"Front Plant Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.31557\/APJCP.2020.21.2.499","volume":"21","author":"Idris H.M.E.","year":"2020","unstructured":"Idris H.M.E.; Elderdery A.Y.; Khalil H.B.; Mills J.; Genetic polymorphism of GSTP1, GSTM1 and GSTT1 genes and susceptibility to chronic myeloid leukaemia. Asian Pac J Cancer Prev 2020,21(2),499-503","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.7150\/jca.15494","volume":"7","author":"Wang Y.","year":"2016","unstructured":"Wang Y.; He J.; Ma T.J.; Lei W.; Li F.; Shen H.; Shen Z.Y.; GSTT1 null genotype significantly increases the susceptibility to urinary system cancer: Evidences from 63,876 subjects. J Cancer 2016,7(12),1680-1693","journal-title":"J Cancer"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.leukres.2007.02.003","volume":"31","author":"Bajpai P.","year":"2007","unstructured":"Bajpai P.; Tripathi A.K.; Agrawal D.; Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Leuk Res 2007,31(10),1359-1363","journal-title":"Leuk Res"},{"key":"ref=26","first-page":"1360","volume":"46","author":"Ovsepian V.A.","year":"2010","unstructured":"Ovsepian V.A.; Vinogradova E.Iu.; Sherstneva E.S.; Cytochrome P4501A1, glutathione S-transferase M1 and T1 gene polymorphisms in chronic myeloid leukemia. Genetika 2010,46(10),1360-1362","journal-title":"Genetika"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/sj.thj.6200555","volume":"5","author":"Tsabouri S.","year":"2004","unstructured":"Tsabouri S.; Georgiou I.; Katsaraki A.; Bourantas K.L.; Glutathione sulfur transferase M1 and T1 genotypes in chronic lymphoblastic leukemia. Hematol J 2004,5(6),500-504","journal-title":"Hematol J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ejca.2005.01.014","volume":"41","author":"Ye Z.","year":"2005","unstructured":"Ye Z.; Song H.; Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: A systematic review and meta-analysis. Eur J Cancer 2005,41(7),980-989","journal-title":"Eur J Cancer"},{"key":"ref=29","first-page":"3861","volume":"14","author":"Zhou L.","year":"2013","unstructured":"Zhou L.; Zhu Y-Y.; Zhang X-D.; Li Y.; Liu Z-G.; Risk effects of GST gene polymorphisms in patients with acute myeloid leukemia: A prospective study. APJCP 2013,14(6),3861-3864","journal-title":"APJCP"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3109\/10428194.2012.706284","volume":"54","author":"Bin Q.","year":"2013","unstructured":"Bin Q.; Luo J.; Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in Hodgkin and non-Hodgkin lymphoma risk: A Human Genome Epidemiology (HuGE). review Leuk Lymphoma 2013,54(1),14-20","journal-title":"Leuk Lymphoma"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s13277-012-0623-9","volume":"34","author":"Wei Y.","year":"2013","unstructured":"Wei Y.; Zhou T.; Lin H.; Sun M.; Wang D.; Li H.; Li B.; Significant associations between GSTM1\/GSTT1 polymorphisms and nasopharyngeal cancer risk. Tumour Biol 2013,34(2),887-894","journal-title":"Tumour Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10528-015-9698-5","volume":"54","author":"Kimi L.","year":"2016","unstructured":"Kimi L.; Ghatak S.; Yadav R.P.; Chhuani L.; Lallawmzuali D.; Pautu J.L.; Senthil Kumar N.; Relevance of GSTM1, GSTT1 and GSTP1 gene polymorphism to breast cancer susceptibility in Mizoram population. Northeast India Biochem Genet 2016,54(1),41-49","journal-title":"Northeast India Biochem Genet"},{"key":"ref=33","first-page":"2921","volume":"19","author":"Adibhesami G.","year":"2018","unstructured":"Adibhesami G.; Shahsavari G.R.; Amiri A.; Emami Razavi A.N.; Shamaei M.; Birjandi M.; Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) Polymorphisms and lung cancer risk among a select group of Iranian people. APJCP 2018,19(10),2921-2927","journal-title":"APJCP"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/jjco\/hyu121","volume":"44","author":"He H.R.","year":"2014","unstructured":"He H.R.; You H.S.; Sun J.Y.; Hu S.S.; Ma Y.; Dong Y.L.; Lu J.; Glutathione S-transferase gene polymorphisms and susceptibility to acute myeloid leukemia: Meta-analyses. J Clin Oncol 2014,44(11),1070-1081","journal-title":"J Clin Oncol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00432-014-1868-z","volume":"141","author":"Mota P.","year":"2015","unstructured":"Mota P.; Silva H.C.; Soares M.J.; Pego A.; Loureiro M.; Cordeiro C.R.; Regateiro F.J.; Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility. J Cancer Res Clin Oncol 2015,141(5),851-860","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15017551","volume":"15","author":"Khabaz M.N.","year":"2016","unstructured":"Khabaz M.N.; Nedjadi T.; Gari M.A.; Al-Maghrabi J.A.; Atta H.M.; Bakarman M.; Gazzaz Z.J.; GSTM1 gene polymorphism and the risk of colorectal cancer in a Saudi Arabian population. Genet Mol Res 2016,15(1)","journal-title":"Genet Mol Res"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"S993","DOI":"10.4103\/0973-1482.191067","volume":"14","author":"Chen D-K.","year":"2018","unstructured":"Chen D-K.; Huang W-W.; Li L-J.; Pan Q-W.; Bao W-S.; Glutathione S-transferase M1 and T1 null genotypes and bladder cancer risk: A meta-analysis in a single ethnic group. J Cancer Res Ther 2018,14(12),S993-S997","journal-title":"J Cancer Res Ther"}],"container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568009623666221027103845","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/210411\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568009623666221027103845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T13:16:23Z","timestamp":1678367783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/210411\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568009623666221027103845","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}